West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Sales | 316,300 | 295,400 | 293,600 | 307,900 | 295,400 |
| Cost of Goods | 215,200 | 210,100 | 212,200 | 223,300 | 207,400 |
| Gross Profit | 101,100 | 85,300 | 81,400 | 84,600 | 88,000 |
| Operating Expenses | 59,600 | 58,500 | 55,500 | 57,100 | 59,600 |
| Operating Income | 41,700 | 26,900 | 26,100 | 27,800 | 28,800 |
| Interest Expense | 4,300 | 4,400 | 4,500 | 4,600 | 4,700 |
| Other Income | 1,600 | 1,900 | 1,900 | 2,200 | 1,600 |
| Pre-tax Income | 39,000 | 24,400 | 23,500 | 25,400 | 25,700 |
| Income Tax | 9,800 | 5,500 | 6,600 | 5,300 | 6,100 |
| Net Income Continuous | 29,200 | 18,900 | 16,900 | 20,100 | 19,600 |
| Net Income | $29,200 | $18,900 | $16,900 | $20,100 | $19,600 |
| EPS Basic Total Ops | 0.43 | 0.28 | 0.25 | 0.30 | 0.30 |
| EPS Basic Continuous Ops | 0.43 | 0.28 | 0.25 | 0.30 | 0.29 |
| EPS Diluted Total Ops | 0.41 | 0.27 | 0.25 | 0.29 | 0.28 |
| EPS Diluted Continuous Ops | 0.39 | 0.25 | 0.23 | 0.27 | 0.27 |
| EBITDA(a) | $60,300 | $45,300 | $44,600 | $47,100 | $48,300 |